Results 51 to 60 of about 36,868 (221)

Xanthogranulomatous cholecystitis

open access: yesJournal of British Surgery, 1990
Abstract This short review discusses the incidence, cause and methods of diagnosis of Xanthogranulomatous cholecystitis. The association between the condition and gallbladder cancer is also considered.
openaire   +2 more sources

Cholecystitis and hemobilia

open access: yesJournal of Surgical Case Reports, 2019
AbstractHemobilia, or hemorrhage into the biliary system, is an unusual cause of gastrointestinal bleeding most commonly seen in accidental or iatrogenic trauma. We present the rare case of a 43-year-old gentleman who presents with an intrahepatic pseudoaneurysm caused by cholecystitis.
Staszak, Jessica K   +2 more
openaire   +2 more sources

Incidental Findings From Treatment Response Monitoring in Oncological Care: Ethical Reflections

open access: yesBioethics, EarlyView.
ABSTRACT The question of how to handle incidental findings in medicine has attracted a lot of attention in the bioethics literature. The most widely discussed examples come from genetics (e.g., next generation sequencing) and medical imaging (e.g., neuroimaging).
Jasper Debrabander   +2 more
wiley   +1 more source

Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings

open access: yesAsian Journal of Surgery, 2016
Background: Radioembolization with yttrium microspheres is an established therapeutic modality for primary and secondary hepatic malignancies, with studies demonstrating improved overall survival.
Sagun Parakh   +3 more
doaj   +1 more source

Diagnosing gangrenous cholecystitis on computed tomography using deep learning: A preliminary study

open access: yesAcute Medicine & Surgery, 2022
Aim To compare deep learning and experienced physicians in diagnosing gangrenous cholecystitis using computed tomography images and explore the feasibility of diagnostic assistance for acute cholecystitis requiring emergency surgery.
Yoichi Okuda   +8 more
doaj   +1 more source

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders

open access: yesBritish Journal of Pharmacology, EarlyView.
Chronic visceral pain imposes a major clinical challenge in gastroenterology and beyond, profoundly impacting patients' quality of life. However, limited understanding of its complex, multifaceted pathophysiology, encompassing both peripheral and central mechanisms, continues to impede the development of effective management strategies.
Fleur Veldman   +3 more
wiley   +1 more source

Longest survivor of pulmonary atresia with ventricular septal defect without surgical intervention

open access: yes
ESC Heart Failure, Volume 12, Issue 2, Page 1499-1507, April 2025.
Sang Zhou   +5 more
wiley   +1 more source

Cardiorenal Mortality and Safety Outcomes of GLP‐1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m2: A Target Trial Emulation

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiorenal evidence for glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) derives mainly from trials in overweight or obesity; data in adults with Type 2 diabetes (T2D) and body mass index (BMI) below 27 kg/m2 are limited. Materials and Methods We emulated a target trial in the TriNetX US Collaborative Network (index dates 2020 to ...
Shao‐Chia Chen   +6 more
wiley   +1 more source

Xanthogranulomatous Cholecystitis.

open access: yesThe Kurume Medical Journal, 2001
Seven cases of xanthogranulomatous cholecystitis are presented, and their clinicopathological appearance is described. Three men and 4 women with xanthogranulomatous cholecystitis, aged 53-72 years old, were reviewed. Five patients had had previous attacks of acute cholecystitis lasting from 3 weeks to 6 months.
ERIGUCHI, NAOFUMI   +8 more
openaire   +3 more sources

Biliary Abnormality on Imaging During Lenvatinib Plus Hepatic Arterial Infusion Chemotherapy With Cisplatin for Hepatocellular Carcinoma: A Pilot Descriptive Study

open access: yesHepatology Research, EarlyView.
ABSTRACT Aim To evaluate the frequency, imaging characteristics, associated factors, and clinical significance of biliary abnormalities on imaging in patients receiving lenvatinib (LEN) plus cisplatin hepatic arterial infusion chemotherapy (HAIC) for hepatocellular carcinoma (HCC).
Hirohito Osanai   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy